Milan: negative performance for Philogen
(Teleborsa) - The Developer of biopharmaceutical products for the treatment of life-threatening conditions slides steadily, trading -1.97% down on previous levels.In the last week Philogen underperformed the FTSE Italia Mid Cap index, therefore showing a lower performance than the benchmark.
Philogen's short-term technicals show its bullish trend running out of steam as it tests resistance at 19.97. First support is seen at 19.87. Expect a negative continuation towards the 19.83 level in the immediate future.
These analyses are to be considered solely for information purposes and are not in any way intended to constitute financial advice, a solicitation of funds from the public or the promotion of any form of investment.
(Teleborsa Research Department)
(Teleborsa) 10-31-2024 12:30 PM